Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

International Hepatology

Home » International Hepatology » Page 10
Collaboration in HPB Health: Highlights from the 9th Academic Symposium of the Chinese Chapter of IHPBA

Collaboration in HPB Health: Highlights from the 9th Academic Symposium of the Chinese Chapter of IHPBA

Posted by By Mourabit Halima 2024.11.14
The 9th Academic Symposium of the Chinese Chapter of the International Hepato-Pancreato-Biliary Association (IHPBA) concluded successfully, underscoring major strides in global HPB collaboration. Hosted by Dr. Lanfei Cheng, the symposium…
Read More
Dr. Ying Han: Early Diagnosis and Intervention Strategies for Refractory Primary Biliary Cholangitis

Dr. Ying Han: Early Diagnosis and Intervention Strategies for Refractory Primary Biliary Cholangitis

Posted by By Peter W. PENG 2024.11.11
Editor’s Note: With shifts in the global landscape of liver diseases, the incidence of primary biliary cholangitis (PBC) has been rising annually. In China, PBC’s prevalence has reached the highest…
Read More
Chairman’s Interview | Dr. Shuangsuo Dang: Ten Years on the Road, Exploring New Trends in Hepatology in the Western Regions

Chairman’s Interview | Dr. Shuangsuo Dang: Ten Years on the Road, Exploring New Trends in Hepatology in the Western Regions

Posted by By Lisa Cui 2024.11.08
The Silk Road begins in Chang'an, with the sounds of camel bells echoing through history. From October 17 to 19, the 10th "Silk Road Hepatology" Academic Conference was held in…
Read More
PNAS丨Dr. Wenshi Wang’s Team from Xuzhou Medical University Unveils Key Molecular Mechanisms of Cross-Species Transmission of Rat HEV

PNAS丨Dr. Wenshi Wang’s Team from Xuzhou Medical University Unveils Key Molecular Mechanisms of Cross-Species Transmission of Rat HEV

Posted by By Peng Longmei 2024.11.07
Hepatitis E virus (HEV) is the leading cause of acute viral hepatitis globally, infecting 20 million people annually and resulting in approximately 60,000 deaths. HEV, part of the Hepeviridae family…
Read More
ILCA Chair Interview | Dr. Tim Meyer: Focusing on Advances in Liver Cancer Treatment and Shaping Future Progress

ILCA Chair Interview | Dr. Tim Meyer: Focusing on Advances in Liver Cancer Treatment and Shaping Future Progress

Posted by By Lisa Cui 2024.11.06
From October 17 to 19, 2024, in the season of golden autumn, the 18th International Liver Cancer Association (ILCA) Annual Conference was successfully held. This grand event attracted numerous top…
Read More
Call for Papers by November 24丨Beijing APASL 2025 Annual Meeting, Inviting Liver Disease Research Experts to Participate

Call for Papers by November 24丨Beijing APASL 2025 Annual Meeting, Inviting Liver Disease Research Experts to Participate

Posted by By Peng Longmei 2024.11.04
The highly anticipated 34th Annual Meeting of the Asia-Pacific Association for the Study of the Liver (APASL 2025) will be held in Beijing from March 26 to 30, 2025. This…
Read More
ESMO China Voice: Personalized ctDNA Methylation for Monitoring MRD Post-Liver Cancer Resection by Fan Jia, Jian Zhou & Xinrong Yang’s Team

ESMO China Voice: Personalized ctDNA Methylation for Monitoring MRD Post-Liver Cancer Resection by Fan Jia, Jian Zhou & Xinrong Yang’s Team

Posted by By Lisa Cui 2024.10.28
Amidst the serene morning mist gracing the wutong trees and frost enhancing the ripeness of oranges, the 2024 Annual Meeting of the European Society for Medical Oncology (ESMO) unfolds in…
Read More
Advancing Liver Cancer Treatment: Insights from Professor Tim Meyer

Advancing Liver Cancer Treatment: Insights from Professor Tim Meyer

Posted by By Peng Longmei 2024.10.23
In a recent discussion, Professor Tim Meyer highlighted the importance of multidisciplinary care in liver cancer treatment. As systemic therapies evolve, including combinations of tyrosine kinase inhibitors and immunotherapy, there’s…
Read More
Metabolic-Related Diseases in Autoimmune Hepatitis Patients Promote Liver Fibrosis

Metabolic-Related Diseases in Autoimmune Hepatitis Patients Promote Liver Fibrosis

Posted by By Peter W. PENG 2024.10.21
Introduction: Autoimmune hepatitis (AIH) is a chronic liver disease that affects both men and women, with about 30% of AIH cases occurring in individuals over 60 years old. Metabolic syndrome,…
Read More
Mesenchymal Stem Cell-Derived Exosomes Alleviate Liver Fibrosis

Mesenchymal Stem Cell-Derived Exosomes Alleviate Liver Fibrosis

Posted by By Mourabit Halima 2024.10.20
Despite increasing knowledge of the cellular and molecular mechanisms underlying liver fibrosis, no Western medicine has been approved to treat the condition. Mesenchymal stem cells (MSCs), which are multipotent progenitor…
Read More

Posts pagination

Previous page 1 … 8 9 10 11 12 … 20 Next page
Recent Posts
  • 19th CUA Genitourinary Oncology Conference | Professor Baojun Wang: Breaking Through the Bottlenecks in Prostate Cancer Treatment—Balancing Clinical Innovation with Standardized Care
  • 19th CUA Genitourinary Oncology Conference | Professor Xuesong Li: Advancing the UTUC Subspecialty Through High-Quality Research to Address Key Clinical Challenges
  • 19th CUA Genitourinary Oncology Conference | Professor Kan Gong: Taking a Pragmatic View of AI in Clinical Practice While Building a China-Specific Evidence Base for Urologic Oncology
  • Blood Advances Study | Director Zhihui Li’s Team Demonstrates Survival Benefit of HSCT in Advanced ENKTCL, Paving the Way for Precision Risk Stratification
  • BCJ Publishes Chinese CMML Cohort Study | Simpler Variables, More Accurate Risk Stratification? Investigators Discuss Why the BLAST Model Outperformed CPSS
Recent Comments
    Archives
    • August 2026
    • July 2026
    • June 2026
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top